Metformin Sandoz 500 mg Tablets | Indications & Buy Online

Metformin Sandoz 500 mg is a highly effective oral hypoglycemic agent and a cornerstone in the pharmacological management of Type 2 Diabetes Mellitus. As a biguanide, it is specifically indicated for patients whose blood glucose levels remain uncontrolled despite rigorous adherence to diet and physical activity. It is the preferred first-line preparation for adult patients with excess body weight, as it helps reduce macrovascular and microvascular complications. Metformin Sandoz can be utilized as a standalone monotherapy or integrated into complex treatment regimens alongside other oral antidiabetics or insulin, catering to both adults and pediatric populations from the age of 10.

Composition and Active Substance

Each film-coated tablet is meticulously formulated for therapeutic consistency:

• Active Substance: Metformin hydrochloride — 500 mg.

• Excipients: Povidone, magnesium stearate.

• Film Coating: Hypromellose, titanium dioxide (E 171), and macrogol 4000.

Pharmacological Action

Metformin Sandoz targets hyperglycemia through a multi-faceted biological approach that does not trigger excessive insulin secretion:

1. Hepatic Control: It significantly decreases hepatic glucose production by inhibiting the processes of gluconeogenesis and glycogenolysis.

2. Cellular Sensitivity: It enhances the sensitivity of peripheral tissues (especially skeletal muscle) to insulin, facilitating improved glucose uptake and disposal.

3. Absorption Modulation: It delays the absorption of glucose from the intestinal tract.

Unlike sulfonylureas, metformin does not cause weight gain and has a minimal risk of hypoglycemia when used alone. It also exerts a positive influence on lipid metabolism, helping to maintain healthy cholesterol levels.

Indications for Use

• Type 2 Diabetes Mellitus: Management in adults and children/adolescents (10+ years).

• First-line Therapy: Ideal for overweight patients to minimize long-term diabetic complications.

• Combination Therapy: Compatible with insulin or other oral hypoglycemic agents for synergistic glycemic control.

Contraindications

• Hypersensitivity to metformin or any tablet components.

• Metabolic Acidosis: Any acute form, including lactic acidosis or diabetic ketoacidosis.

• Severe Renal Impairment: Glomerular filtration rate (GFR) < 30 ml/min.

• Hypoxia-inducing Conditions: Decompensated heart failure, respiratory failure, or recent myocardial infarction.

• Acute Risks: Severe dehydration, shock, or severe infectious diseases.

• Liver Health: Liver failure, acute alcohol poisoning, or chronic alcoholism.

Dosage and Administration

Adult Patients:

• Initial Dose: Usually 500 mg taken 2–3 times daily.

• Titration: After 10–15 days, adjust the dose based on blood serum glucose measurements.

• Maximum Dose: 3000 mg per day, divided into 3 doses.

• Switching: When transitioning from another antidiabetic agent, stop the previous medication before starting Metformin Sandoz.

Children and Adolescents (10+ Years):

• Regimen: Monotherapy or combined with insulin. The initial dose and titration follow the adult protocol, ensuring slow increases to protect the digestive tract.

Special Administration Tips

• Meal Coordination: Take tablets during or after meals to prevent stomach upset.

• Elderly Patients: Dosage should be carefully adjusted based on regular renal function assessments.

Side Effects and Adverse Reactions

• Gastrointestinal (Very Frequent): Nausea, vomiting, diarrhea, flatulence, abdominal pain, and lack of appetite. These usually occur at the start and fade spontaneously.

• Nervous System (Frequent): Changes in taste (metallic sensation).

• Metabolic (Rare): Lactic acidosis. Long-term use may lead to Vitamin B12 deficiency (megaloblastic anemia).

• Hepatobiliary: Isolated cases of impaired liver function tests or hepatitis.

Special Precautions & Warnings

• Lactic Acidosis: A rare but life-threatening emergency. If symptoms like muscle cramps or severe weakness occur, stop the drug and seek immediate hospitalization.

• Pregnancy: While data is limited, insulin is typically recommended during pregnancy to maintain the strictest possible glucose control.

• Breastfeeding: Not recommended due to metformin being excreted in breast milk and insufficient safety data.

• Driving: Monotherapy is safe; however, risks of hypoglycemia arise when combined with sulfonylureas, insulin, or meglitinides.

Storage Conditions and Shelf Life

• No special temperature storage conditions are required, but it is best kept in a cool, dry place.

• Ensure the medication is kept in its original packaging and out of the reach of children.

• Shelf Life: Refer to the expiration date on the package.